Literature DB >> 10760359

Purinergic modulation of [(3)H]GABA release from rat hippocampal nerve terminals.

R A Cunha1, J A Ribeiro.   

Abstract

The hippocampal GABAergic system is assumed not to be a target for purine modulation. We have now confirmed that neither adenosine A(1) and A(3) receptor nor nucleotide P(2) or P(4) receptor activation modified the K(+)-evoked [(3)H]GABA release from hippocampal synaptosomes. However, activation of adenosine A(2A) receptors with CGS 21680 (10 nM) or HENECA (30 nM) facilitated GABA release by 32% and 21%, respectively. These effects were prevented by the A(2A) antagonist, ZM 241385 (20 nM). A(2A) receptors may activate adenylate cyclase and protein kinase A since CGS 21680 (10 nM) facilitation was partially prevented by 8-bromo-cAMP (1 mM), forskolin (10 microM) and HA-1004 (10 microM). Protein kinase C may also be recruited, since chelerythrine (6 microM) and phorbol-12, 13-didecanoate (250 nM) attenuated CGS 21680 (10 nM) facilitation of [(3)H]GABA release. Omega-agatoxin-IVA (200 nM) occluded CGS 21680 facilitation suggesting the involvement of P-type calcium channels. Thus, the adenosine A(2A) receptor system appears to be one of the first presynaptic neuromodulatory systems able to enhance the evoked release of GABA from hippocampal nerve terminals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10760359     DOI: 10.1016/s0028-3908(99)00237-3

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  29 in total

1.  Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9-tetrahydrocannabinol on spatial memory.

Authors:  Vasco C Sousa; Natália Assaife-Lopes; Joaquim A Ribeiro; Judith A Pratt; Ros R Brett; Ana M Sebastião
Journal:  Neuropsychopharmacology       Date:  2010-10-06       Impact factor: 7.853

2.  Binding of adenosine receptor ligands to brain of adenosine receptor knock-out mice: evidence that CGS 21680 binds to A1 receptors in hippocampus.

Authors:  Linda Halldner; Luisa V Lopes; Elisabetta Daré; Karin Lindström; Björn Johansson; Catherine Ledent; Rodrigo A Cunha; Bertil B Fredholm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-09-18       Impact factor: 3.000

Review 3.  Purinergic signalling in neuron-glia interactions.

Authors:  R Douglas Fields; Geoffrey Burnstock
Journal:  Nat Rev Neurosci       Date:  2006-06       Impact factor: 34.870

4.  Extracellular interconversion of nucleotides reveals an ecto-adenylate kinase activity in the rat hippocampus.

Authors:  Beáta Sperlágh; E Sylvester Vizi
Journal:  Neurochem Res       Date:  2007-08-25       Impact factor: 3.996

5.  NTS adenosine A2a receptors inhibit the cardiopulmonary chemoreflex control of regional sympathetic outputs via a GABAergic mechanism.

Authors:  Zeljka Minic; Donal S O'Leary; Tadeusz J Scislo
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-04-24       Impact factor: 4.733

6.  Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis.

Authors:  Attila Köfalvi; Ricardo J Rodrigues; Catherine Ledent; Ken Mackie; E Sylvester Vizi; Rodrigo A Cunha; Beáta Sperlágh
Journal:  J Neurosci       Date:  2005-03-16       Impact factor: 6.167

7.  GABA release modified by adenosine receptors in mouse hippocampal slices under normal and ischemic conditions.

Authors:  Pirjo Saransaari; Simo S Oja
Journal:  Neurochem Res       Date:  2005-04       Impact factor: 3.996

8.  Adenosine A(2A) receptors in psychopharmacology: modulators of behavior, mood and cognition.

Authors:  Hai-Ying Shen; Jiang-Fan Chen
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

9.  Tuning and fine-tuning of synapses with adenosine.

Authors:  A M Sebastião; J A Ribeiro
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

Review 10.  Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders.

Authors:  Rodrigo A Cunha; Sergi Ferré; Jean-Marie Vaugeois; Jiang-Fan Chen
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.